755 related articles for article (PubMed ID: 25567525)
21. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
22. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
[TBL] [Abstract][Full Text] [Related]
23. Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.
Lu J; Cuellar K; Hammer NI; Jo S; Gryczke A; Kolter K; Langley N; Repka MA
Drug Dev Ind Pharm; 2016; 42(3):485-96. PubMed ID: 26530290
[TBL] [Abstract][Full Text] [Related]
24. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
25. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
26. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396
[TBL] [Abstract][Full Text] [Related]
27. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
28. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
29. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
[TBL] [Abstract][Full Text] [Related]
30. Stability assessment of hypromellose acetate succinate (HPMCAS) NF for application in hot melt extrusion (HME).
Sarode AL; Obara S; Tanno FK; Sandhu H; Iyer R; Shah N
Carbohydr Polym; 2014 Jan; 101():146-53. PubMed ID: 24299759
[TBL] [Abstract][Full Text] [Related]
31. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
32. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
34. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
35. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
36. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
Kalivoda A; Fischbach M; Kleinebudde P
Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
[TBL] [Abstract][Full Text] [Related]
37. Effect of melt extrudability and melt binding efficiency of polyvinyl caprolactam polyvinyl acetate polyethylene glycol graft copolymer (Soluplus®) on release pattern of hydrophilic and high dose drugs.
Tousif Ayyub K; Moravkar K; Maniruzzaman M; Amin P
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():563-574. PubMed ID: 30889730
[TBL] [Abstract][Full Text] [Related]
38. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
[TBL] [Abstract][Full Text] [Related]
39. Application of HPMC HME polymer as hot melt extrusion carrier in carbamazepine solid dispersion.
Wu H; Liu Y; Ci T; Ke X
Drug Dev Ind Pharm; 2020 Dec; 46(12):1911-1918. PubMed ID: 32942902
[TBL] [Abstract][Full Text] [Related]
40. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
